NYSEMKT:BTI

British American Tobacco P.l.c Stock News

etoro logo Buy BTI
*Your capital is at risk
$57.85
-0.770 (-1.31%)
At Close: Jun 04, 2026
British American Tobacco is growing alternative tobacco categories rapidly. Growing customer adoption of vape products implies strong growth prospects, especially in the U.S. market.
The surprising stock market sector stars have more room to run.
British American Tobacco might see its profits from e-cigarettes double due to the ban on rival Juul, according to brokers at Barclays. The UK business owns rival Vuse, which is in a prime position to
The FDA's plan to reduce nicotine in cigarettes to near zero could mean big sales for this stock.

The FDA Could Soon Crown This E-Cig Maker King

10:37am, Saturday, 25'th Jun 2022
The soon-to-be-undisputed e-cig leader is on a roll.
British American Tobacco should take some positives from yesterday's US banning of Juul's e-cigarette products, according to broker Jefferies. The broker notes that the denial/ban is based on insuffi
Even if the market has not yet reached the point of bottoming-out, these seven undervalued large-cap stocks are worth a look. The post 7 Undervalued Large-Cap Stocks to Buy Before Wall Street Catches
British American Tobacco PLC (LON:BATS) has returned 23.99% to investors year-to-date. Imperial Brands PLC (LON:IMB) has 10.34% returns in the same period.
These stocks offer dividend yields ranging from 2% to an astronomical 7.1%.
BAT Industries has received a strong endorsement from analysts at JP Morgan, which sees the tobacco giant having scope to build on its 27% rise this year. “With its strong pricing power, undemanding
Well, that didn't last long. As we suspected, each and every market rally until the Federal Reserve completes the interest rate hike cycle likely will be met with selling as investors try to go to cas

Bioasis Acquires Phase 2 Ready Rare Orphan EGF Assets

11:50am, Thursday, 16'th Jun 2022 GlobeNewswire Inc.
Phase 2 ready assets transform Bioasis into a clinical stage company with a multi-asset pipeline focused on rare and orphan drug indications
NEW HAVEN, Conn., June 14, 2022 (GLOBE NEWSWIRE) -- BIOASIS TECHNOLOGIES INC. (TSXV:BTI.V; OTCQB:BIOAF), (the “Company” or “Bioasis”), a biopharmaceutical company developing its proprietary
Economic and competitive threats shouldn't slow down this tobacco giant much.
BTI is a high margin cash cow that is still too cheap, with a single digit earnings multiple (9.7x). Investors should monitor the debt levels, which are a bit elevated. The company has paid back a lar
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE